Literature DB >> 21449728

Activation of NK cells by ADCC responses during early HIV infection.

Amy W Chung1, Marjon Navis, Gamze Isitman, Rob Centre, Robert Finlayson, Mark Bloch, Linda Gelgor, Antony Kelleher, Stephen J Kent, Ivan Stratov.   

Abstract

Partial control of HIV occurs during acute infection, although the mechanisms responsible are poorly understood. We studied the ability of antibody-dependent cellular cytotoxicity (ADCC) antibodies in serum to activate natural killer (NK) cells in longitudinal samples from 8 subjects with well-defined early HIV infection who controlled viremia to low levels. NK cell activation by ADCC antibodies to gp140 Env proteins was detected in half of the subjects at the first time point studied, a mean of 111 d after the estimated time of infection. In contrast, ADCC-mediated NK cell activation in response to linear HIV peptides evolved more slowly, over the first 2 y of infection. Our studies suggest that HIV-specific ADCC responses to conformational epitopes occur early during acute HIV infection, and broaden to include linear epitopes over time. These findings have implications for the immune control of HIV.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21449728      PMCID: PMC3070001          DOI: 10.1089/vim.2010.0108

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  18 in total

1.  Hepatitis B virus e antigen specific epitopes and limitations of commercial anti-HBe immunoassays.

Authors:  M A Baumeister; A Medina-Selby; D Coit; S Nguyen; C George-Nascimento; A Gyenes; P Valenzuela; G Kuo; D Y Chien
Journal:  J Med Virol       Date:  2000-03       Impact factor: 2.327

2.  Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells.

Authors:  D N Forthal; G Landucci; E S Daar
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Evaluation of passively transferred, nonneutralizing antibody-dependent cellular cytotoxicity-mediating IgG in protection of neonatal rhesus macaques against oral SIVmac251 challenge.

Authors:  Ruth H Florese; Koen K A Van Rompay; Kris Aldrich; Donald N Forthal; Gary Landucci; Madhumita Mahalanabis; Nancy Haigwood; David Venzon; Vaniambadi S Kalyanaraman; Marta L Marthas; Marjorie Robert-Guroff
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

4.  HIV-specific cellular and humoral immune responses in primary HIV infection.

Authors:  E Connick; D G Marr; X Q Zhang; S J Clark; M S Saag; R T Schooley; T J Curiel
Journal:  AIDS Res Hum Retroviruses       Date:  1996-08-10       Impact factor: 2.205

5.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

6.  Trends in antiretroviral treatment use and treatment response in three Australian states in the first decade of combination antiretroviral treatment.

Authors:  Kathleen Falster; Linda Gelgor; Ansari Shaik; Iryna Zablotska; Garrett Prestage; Jeffrey Grierson; Rachel Thorpe; Marian Pitts; Jonathan Anderson; John Chuah; Brian Mulhall; Kathy Petoumenos; Anthony Kelleher; Matthew Law
Journal:  Sex Health       Date:  2008-06       Impact factor: 2.706

7.  Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.

Authors:  P Borrow; H Lewicki; B H Hahn; G M Shaw; M B Oldstone
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  Rapid degranulation of NK cells following activation by HIV-specific antibodies.

Authors:  Amy W Chung; Erik Rollman; Rob J Center; Stephen J Kent; Ivan Stratov
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

9.  Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection.

Authors:  L A Sawyer; D A Katzenstein; R M Hendry; E J Boone; L K Vujcic; C C Williams; S L Zeger; A J Saah; C R Rinaldo; J P Phair
Journal:  AIDS Res Hum Retroviruses       Date:  1990-03       Impact factor: 2.205

10.  High viral fitness during acute HIV-1 infection.

Authors:  Alicia Arnott; Darren Jardine; Kim Wilson; Paul R Gorry; Kate Merlin; Patricia Grey; Matthew G Law; Elizabeth M Dax; Anthony D Kelleher; Don E Smith; Dale A McPhee
Journal:  PLoS One       Date:  2010-09-09       Impact factor: 3.240

View more
  26 in total

1.  HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV.

Authors:  Vijaya Madhavi; Bruce D Wines; Janaki Amin; Sean Emery; Ester Lopez; Anthony Kelleher; Rob J Center; P Mark Hogarth; Amy W Chung; Stephen J Kent; Ivan Stratov
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

2.  Exploring the potential of monoclonal antibody therapeutics for HIV-1 eradication.

Authors:  Zelda Euler; Galit Alter
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

3.  Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection.

Authors:  Leia H Wren; Amy W Chung; Gamze Isitman; Anthony D Kelleher; Matthew S Parsons; Janaki Amin; David A Cooper; Ivan Stratov; Marjon Navis; Stephen J Kent
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

Review 4.  Role of Fc-mediated antibody function in protective immunity against HIV-1.

Authors:  George K Lewis
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

5.  Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding.

Authors:  Yongjun Guan; Marzena Pazgier; Mohammad M Sajadi; Roberta Kamin-Lewis; Salma Al-Darmarki; Robin Flinko; Elena Lovo; Xueji Wu; James E Robinson; Michael S Seaman; Timothy R Fouts; Robert C Gallo; Anthony L DeVico; George K Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-13       Impact factor: 11.205

6.  Independent evolution of Fc- and Fab-mediated HIV-1-specific antiviral antibody activity following acute infection.

Authors:  Anne-Sophie Dugast; Leonidas Stamatatos; Andrew Tonelli; Todd J Suscovich; Anna F Licht; Iliyana Mikell; Margaret E Ackerman; Hendrik Streeck; P J Klasse; John P Moore; Galit Alter
Journal:  Eur J Immunol       Date:  2014-08-11       Impact factor: 5.532

7.  A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assays.

Authors:  Michael D Alpert; Lisa N Heyer; David E J Williams; Jackson D Harvey; Thomas Greenough; Maria Allhorn; David T Evans
Journal:  J Virol       Date:  2012-08-29       Impact factor: 5.103

8.  Effects on innate immunity of a therapeutic dendritic cell-based vaccine for HIV-1 infection.

Authors:  José Peña; Mario Frías; Laura Castro-Orgaz; Rafael González; Felipe García; Teresa Gallart; Jose María Gatell; Montserrat Plana
Journal:  Viral Immunol       Date:  2012-01-10       Impact factor: 2.257

9.  Frequent and strong antibody-mediated natural killer cell activation in response to HIV-1 Env in individuals with chronic HIV-1 infection.

Authors:  Christina F Thobakgale; Lena Fadda; Kimberly Lane; Ildiko Toth; Florencia Pereyra; Suzane Bazner; Thumbi Ndung'u; Bruce D Walker; Eric S Rosenberg; Galit Alter; Mary Carrington; Todd M Allen; Marcus Altfeld
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

Review 10.  Positive and negative regulation by NK cells in cancer.

Authors:  Can M Sungur; William J Murphy
Journal:  Crit Rev Oncog       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.